Public Calendar: February 1 -7, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 02/03/2026
Location: Silver Spring, MD
Subject: Access to Safe and Effective Over the Counter (OTC) Medicines
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Consumer Healthcare Products Association representatives

Event Date: 02/06/2026
Location: Washington, DC
Subject: Research and Development Leadership Forum
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs
No Significant Event

Official Name: Sean R. Keveney, Chief Counsel
No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods
Event Date: 02/03/2026
Location: Washington, DC
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: National Association of State Departments of Agriculture representatives

Event Date: 02/04/2026
Location: College Park, MD
Subject: Introductory Meeting
FDA Participant/Group: LARRY MORRIS; DONALD PRATER; REBECCA BUCKNER;
Non FDA Participant/Group: American Chemistry Council representatives

Event Date: 02/05/2026
Location: College Park, MD
Subject: Introductory Meeting
FDA Participant/Group: REBECCA BUCKNER; DONALD PRATER; LARRY MORRIS;
Non FDA Participant/Group: Esther Hallam (Nara Organics); Jayme White (Kelley Drye & Warren LLP);

Event Date: 02/06/2026
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Abbie Lennox, Annette Corcoran, Charles Atkinson (Perrigo Company);

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations
No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives
Event Date: 02/04/2026
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: LUKE HALL;
Non FDA Participant/Group: John Nason (Pharmathen); Charles Dallara (Partners Group);

Event Date: 02/05/2026
Location: Washington, DC
Subject: Friends of Cancer Research Public Meeting - Modernizing Oncology Endpoints: Pathways for Evidence and Policy; Panelist: Modernizing Regulatory Frameworks: Future Policies and Priorities
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations
Event Date: 02/03/2026
Location: Washington, DC
Subject: National Association of State Departments of Agriculture (NASDA) Winter Policy Conference
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: National Association of State Departments of Agriculture (NASDA) members and other stakeholders

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research
No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
Event Date: 02/02/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Solventum representatives

Official Name: Tracy Beth Høeg M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research
No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products
No Significant Event

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine
No Significant Event